Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06650215
Starting soon Observational

The 2-minute Walk Test in Hemodialysis Patients

NCT06650215 · tracked via the Priya Life Science Turkey tracker
Sponsor
Kirsehir Ahi Evran Universitesi
Phase
Observational
Started
2024-11
Last updated
2024-11-05

Condition(s) studied

End Stage Renal Disease

Study summary

Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with end stage renal disease receiving hemodialysis * Being clinically stable * Being Aged between 18-80 * Volunteering to participate in this study Exclusion Criteria: * Having a musculoskeletal problem that may affect functional capacity measurement * Having had a cardiac event in the past 3 months

Primary outcome measure(s)

  • Exercise capacity — 5 minutes
    Will be assessed using the 2 minute walk test.
  • Exercise capacity — 10 minutes
    Will be assessed using the 6 minute walk test.
  • Muscle functions — 1 minutes
    Will be evaluated with 1 minute sit-stand test.

Trial sites (1)

FacilityCityRegionStatus
Kirsehir Ahi Evran University Kırşehir Turkey (Türkiye)

More Kirsehir Ahi Evran Universitesi trials in Turkey

The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals Recruiting
Biomarkers in Ankylosing Spondylitis Active, not recruiting
Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis Recruiting
Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index Recruiting
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06650215 on ClinicalTrials.gov ↗ ← All trials in Turkey